MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer

Cancer Gene Therapy

Volumn 22, Issue 6, 2015, Pages 291-301

  Jiang, C ^a   Chen, X ^b   Alattar, M ^c   Wei, J ^d   Liu, H ^e  

^a Tianjin Union Medical Centre   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c ZAGAZIG UNIVERSITY   (Egypt)

^d XIAMEN UNIVERSITY   (China)

^e XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; GENE EXPRESSION; HUMAN; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; METASTASIS; ONCOGENE; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; TREATMENT RESPONSE; TUMOR INVASION; TUMOR SUPPRESSOR GENE; GENETICS; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; TUMOR GENE;

BIOMARKERS, TUMOR; CARCINOGENESIS; GENES, NEOPLASM; HUMANS; MICRORNAS; NEOPLASM METASTASIS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84931559897     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2015.19     Document Type: Review

References (132)

1. Power DG, Kelsen DP, Shah MA. Advanced gastric cancer-slow but steady progress. Cancer Treat Rev 2010; 36: 384-392.
2. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773.
3. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
4. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, De Martino I et al. E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13: 272-286.
5. Espinosa-Parrilla Y, Muñoz X, Bonet C, Garcia N, Venceslá A, Yiannakouris N et al. Genetic association of gastric cancer with miRNA clusters including the cancerrelated genes MIR29, MIR25, MIR93 and MIR106: Results from the EPICEURGAST study. Int J Cancer 2014; 135: 2065-2076.
6. Hashimoto Y, Akiyama Y, Otsubo T, Shimada S, Yuasa Y. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis 2010; 31: 777-784.
7. Yang Q, Xu E, Dai J, Wu J, Zhang S, Peng B et al. miR-21 regulates N-methyl-Nnitro-N′-nitrosoguanidine-induced gastric tumorigenesis by targeting FASLG and BTG2. Toxicol Lett 2014; 228: 147-156.
8. Tu H, Sun H, Lin Y, Ding J, Nan K, Li Z et al. Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21. Curr Pharm Design 2014; 20: 1917-1923.
9. Yang Q, Jie Z, Ye S, Li Z, Han Z, Wu J et al. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene 2012; 33: 193-202.
10. Wada R, Akiyama Y, Hashimoto Y, Fukamachi H, Yuasa Y. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J Cancer 2010; 127: 1106-1114.
11. Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009; 273: 233-242.
12. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009; 24: 652-657.
13. Qin S, Ai F, Ji WF, Rao W, Zhang HC, Yao WJ. miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer. Asian Pac J Cancer Prev 2013; 14: 835-840.
14. Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 2012; 27: 1019-1026.
15. Schetter AJ, Heegaard NHH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010; 31: 37-49.
16. Zhao H, Wang Y, Yang L, Jiang R, Li W. miR-25 promotes gastric cancer cells growth and motility by targeting RECK. Mol Cell Biochem 2014; 385: 207-213.
17. Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C et al. miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol Carcinogen 2013; 52: 634-646.
18. Yang TS, Yang XH, Chen X, Wang XD, Hua J, Zhou DL et al. MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN. FEBS Lett 2014; 588: 2162-2169.
19. Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 2010; 392: 340-345.
20. Zhang X, Nie Y, Du Y, Cao J, Shen B, Li Y. MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. Tumor Biol 2012; 33: 1589-1597.
21. Li J, Guo Y, Liang X, Sun M, Wang G, De W et al. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin 2012; 138: 763-774.
22. Wang M, Li C, Yu B, Su L, Li J, Ju J et al. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol 2013; 48: 1023-1033.
23. Hsu KW, Wang AM, Ping YH, Huang KH, Huang TT, Lee HC et al. Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis. Carcinogenesis 2013; 35: 208-217.
24. Guo SL, Ye H, Teng Y, Wang YL, Yang G, Li XB et al. Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency. Nat Commun 2013; 4: 2544.
25. Cho WJ, Shin JM, Kim JS, Lee MR, Hong KS, Lee JH et al. miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol Cell 2009; 28: 521-527.
26. Zhi Q, Guo X, Guo L, Zhang R, Jiang J, Ji J et al. Oncogenic miR-544 is an important molecular target in gastric cancer. Anticancer Agents Med Chem 2013; 13: 270-275.
27. Zhang S, Feng J, Wang L, Guo W, Du YW, Ming L et al. miR-1303 targets claudin- 18 gene to modulate proliferation and invasion of gastric cancer cells. Digest Dis Sci 2014; 8: 1754-1763.
28. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, Cheng Q. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Digest Dis Sci 2010; 55: 2288-2293.
29. Zhang X, Li X, Tan Z, Liu X, Yang C, Ding X et al. MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis. Oncol Lett 2013; 6: 1427-1434.
30. Yang ZX, Lu CY, Yang YL, Dou KF, Tao KS. MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells. Mol Med Rep 2013; 7: 229-232.
31. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One 2011; 6: e16617.
32. Xiao B, Zhu ED, Li N, Lu DS, Li W, Li BS et al. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep 2012; 27: 559-566.
33. Guo SL, Peng Z, Yang X, Fan KJ, Ye H, Li ZH et al. miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Bio Sci 2011; 7: 567-574.
34. Sun M, Liu X, Li J, Yang JS, Zhang EB, Yin DD et al. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27kip1. Mol Cancer Ther 2012; 11: 842-852.
35. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PloS One 2010; 5: e13247.
36. Wan HY, Guo LM. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 2010; 9: 16.
37. Luo H, Zhang H, Zhang Z, Zhang X, Ning B, Guo J et al. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 2009; 28: 82.
38. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y. MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 2011; 129: 2611-2620.
39. Ma YY, Tao HQ. Microribonucleic acids and gastric cancer. Cancer Sci 2012; 103: 620-625.
40. Lam EKY, Wang X, Shin VY, Zhang S, Morrison H, Sun J et al. A microRNA contribution to aberrant Ras activation in gastric cancer. Am J Transl Res 2011; 3: 209-218.
41. Xu L, Wang F, Xu XF, Mo WH, Xia YJ, Wan R et al. Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells. Med Oncol 2011; 28: 189-196.
42. Li P, Chen X, Su L, Li C, Zhi Q, Yu B et al. Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP. PLoS One 2013; 8: e66782.
43. Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 2010; 20: 784-793.
44. Miao L, Liu K, Xie M, Xing Y, Xi T. miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling. Cancer Immunol Immun 2014; 63: 699-711.
45. Kim K, Lee HC, Park JL, Kim M, Kim SY, Noh SM et al. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 2011; 6: 740-751.
46. Duan Y, Hu L, Liu B, Yu B, Li J, Yan M et al. Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV. Mol Cancer 2014; 13: 127.
47. Gong J, Li J, Wang Y, Liu C, Jia H, Jiang C et al. Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. Carcinogenesis 2014; 35: 497-506.
48. Han TS, Hur K, Xu G, Choi B, Okugawa Y, Toiyama Y et al. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut 2015; 64: 203-214.
49. Peng Y, Guo JJ, Liu YM, Wu XL. MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression. Biosci Rep 2014; 4: 247-256.
50. He XP, Shao Y, Li XL, Xu W, Chen GS, Sun HH et al. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J 2012; 279: 4201-4212.
51. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ et al. MicroRNA-101 is downregulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 2010; 46: 2295-2303.
52. Xia J, Wu Z, Yu C, He W, Zheng H, He Y et al. miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol 2012; 227: 470-480.
53. Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM et al. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 2011; 10: 1-13.
54. Shinozaki A, Sakatani T, Ushiku T, Hino R, Isogai M, Ishikawa S et al. Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res 2010; 70: 4719-4727.
55. Jiping Z, Ming F, Lixiang W, Xiuming L, Yuqun S, Han Y et al. MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2. J Cell Biochem 2013; 114: 2666-2672.
56. Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010; 116: 41-49.
57. Lei H, Zou D, Li Z, Luo M, Dong L, Wang B et al. MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation. PLoS One 2013; 8: e60369.
58. Guo X, Guo L, Ji J, Zhang J, Zhang J, Chen X et al. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun 2010; 398: 1-6.
59. Feng Y, Wang L, Zeng J, Shen L, Liang X, Yu H et al. FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370. Mol Cancer Res 2013; 11: 834-844.
60. Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y et al. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer 2014; 18: 43-54.
61. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K et al. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 2010; 31: 2066-2073.
62. Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichinose M et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009; 124: 2367-2374.
63. Deng H, Guo Y, Song H, Xiao B, Sun W, Liu Z et al. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene 2013; 518: 351-359.
64. Yang Q, Jie Z, Cao H, Greenlee AR, Yang C, Zou F et al. Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis 2011; 32: 713-722.
65. Ji Q, Hao X, Meng Y, Zhang M, DeSano J, Fan D et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008; 8: 266.
66. Chen Q, Chen X, Zhang M, Fan Q, Luo S, Cao X. miR-137 is frequently downregulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci 2011; 56: 2009-2016.
67. Yin WZ, Li F, Zhang L, Ren XP, Zhang N, Wen JF. Down-regulation of MicroRNA-205 promotes gastric cancer cell proliferation. Eur Rev Med Pharmacol 2014; 18: 1027-1032.
68. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3ζ. Cancer Res 2010; 70: 2339-2349.
69. Liu D, Xia P, Diao D, Cheng Y, Zhang H, Yuan D et al. MiRNA-429 suppresses the growth of gastric cancer cells in vitro. J Biomed Res 2012; 26: 389-393.
70. Kheir TB, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C et al. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011; 10: 29.
71. Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L et al. Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep 2010; 24: 105-112.
72. Kong D, Piao YS, Yamashita S, Oshima H, Oguma K, Fushida S et al. Inflammationinduced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 2011; 31: 3949-3960.
73. Feng R, Chen X, Yu Y, Su L, Yu B, Li J et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010; 298: 50-63.
74. Liang S, He L, Zhao X, Miao Y, Gu Y, Guo C et al. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 2011; 6: e18409.
75. Zhao X, Dou W, He L, Liang S, Tie J, Liu C et al. MicroRNA-7 functions as an antimetastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 2012; 32: 1363-1372.
76. Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP, Gao C et al. The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene 2012; 32: 491-501.
77. Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R et al. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clinical. Cancer Res 2011; 17: 7574-7583.
78. Wang SH, Li X, Zhou LS, Cao ZW, Shi C, Zhou CZ et al. microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition. Tumor Biol 2013; 34: 3705-3712.
79. Li CL, Nie H, Wang M, Su LP, Li JF, Yu YY et al. microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis. Oncology Rep 2012; 27: 1960-1966.
80. Ren J, Huang H, Gong Y, Yue S, Tang LM, Cheng SY. MicroRNA-206 suppresses gastric cancer cell growth and metastasis. Cell Biosci 2014; 4: 26.
81. Wang YW, Shi DB, Chen X, Gao C, Gao P. Clinicopathological significance of MicroRNA-214 in gastric cancer and its effect on cell biological behaviour. PLoS One 2014; 9: e91307.
82. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010; 6: e1000879.
83. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang X et al. MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 2011; 31: 1398-1407.
84. Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D et al. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 2012; 31: 4509-4516.
85. Takei Y, Takigahira M, Mihara K, Tarumi Y, Yanagihara K. The metastasisassociated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Cancer Res 2011; 71: 1442-1453.
86. Su Y, Ni Z, Wang G, Cui J, Wei C, Wang J et al. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int Immunopharmacol 2012; 13: 468-475.
87. Wang M, Li C, Nie H, Lv X, Qu Y, Yu B et al. Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett 2012; 586: 2382-2388.
88. Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC et al. Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 2011; 6: 1189-1197.
89. Chen W, Tang Z, Sun Y, Zhang Y, Wang X, Shen Z et al. miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes. Exp Ther Med 2012; 3: 351-356.
90. Li X, Zhang Z, Yu M, Li L, Du G, Xiao W et al. Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int J Mol Sci 2013; 14: 16226-16239.
91. Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008; 88: 1358-1366.
92. Zhang Z, Liu S, Shi R, Zhao G. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet 2011; 204: 486-491.
93. Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y et al. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med 2011; 15: 1887-1895.
94. Guo JX, Tao QS, Lou PR, Chen XC, Chen J, Yuan GB. miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms. Asian Pac J Cancer Prev 2012; 13: 2263-2267.
95. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011; 9: 824-833.
96. Guo XB, Jing CQ, Li LP, Zhang L, Shi YL, Wang JS et al. Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene. World J Gastroenterol 2011; 17: 1895-1902.
97. Huang Q, Gumireddy K, Schrier M, Le Sage C, Nagel R, Nair S et al. The micro-RNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008; 10: 202-210.
98. Chang KW, Liu CJ, Chu TH, Cheng HW, Hung PS, Hu WY et al. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 2008; 87: 1063-1068.
99. Spahn M, Kneitz S, Scholz CJ, Stenger N, Rüdiger T, Ströbel P et al. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 2010; 127: 394-403.
100. Barker EV, Cervigne NK, Reis PP, Goswami RS, Xu W, Weinreb I et al. microRNA evaluation of unknown primary lesions in the head and neck. Mol Cancer 2009; 8: 127.
101. Wu WY, Xue XY, Chen ZJ, Han SL, Huang YP, Zhang LF et al. Potentially predictive microRNAs of gastric cancer with metastasis to lymph node. World J Gastroenterol 2011; 17: 3645-3651.
102. Xu Y, Sun J, Xu J, Li Q, Guo Y, Zhang Q. miR-21 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer. Gastroenterol Res Pract 2012; 2012: 640168.
103. Zhang XL, Zhu WY, Zhang JF, Huo S, Zhou L, Gu Z et al. MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 2010; 395: 275-280.
104. Liu C, Zhang R, Lu Y, Li H, Lu P, Yao F et al. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases. Surg Oncol 2010; 19: 4-10.
105. Jones D, Li Y, He Y, Xu Z, Chen H, Min W. Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis. Arterioscl Throm Vas 2012; 32: 633-642.
106. Clasper S, Royston D, Baban D, Cao Y, Ewers S, Butz S et al. A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res 2008; 68: 7293-7303.
107. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T et al. Circulating microRNAs in plasma of patients with gastric cancers. Brit J Cancer 2010; 102: 1174-1179.
108. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010; 101: 2087-2092.
109. Zheng Y, Cui L, Sun W, Zhou H, Yuan X, Huo M et al. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark 2011; 10: 71-77.
110. Guo B, Li J, Liu L, Hou N, Chang D, Zhao L et al. Dysregulation of miRNAs and their potential as biomarkers for the diagnosis of gastric cancer. Biomed Rep 2013; 1: 907-912.
111. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med 2010; 88: 709-717.
112. Gorur A, Fidanci SB, Unal ND, Ayaz L, Akbayir S, Yaroglu HY et al. Determination of plasma microRNA for early detection of gastric cancer. Mol Biol Rep 2013; 40: 2091-2096.
113. Song M, Pan K, Su H, Zhang L, Ma JL, Li JY et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 2012; 7: e33608.
114. Chan SH, Wu CW, Li AFY, Chi CW, Lin WC. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008; 28: 907-911.
115. Motoyama K, Inoue H, Mimori K, Tanaka F, Kojima K, Uetake H et al. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol 2010; 36: 1089-1095.
116. Li B, Zhao Y, Guo G, Li W, Zhu ED, Luo X et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 2012; 7: e41629.
117. Zhang Y, Guo J, Li D, Xiao B, Miao Y, Jiang Z et al. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med Oncol 2010; 27: 685-689.
118. Li X, Luo F, Li Q, Xu M, Feng D, Zhang G et al. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. Oncol Rep 2011; 26: 1431-1439.
119. Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y et al. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 2009; 400: 97-102.
120. Zhang WH, Gui JH, Wang CZ, Chang Q, Xu SP, Cai CH et al. The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma. Oncol Res 2012; 20: 139-147.
121. Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D et al. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 2010; 45: 17-23.
122. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010; 11: 136-146.
123. Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H et al. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer 2013; 119: 1618-1626.
124. Zhang X, Cui L, Ye G, Zheng T, Song H, Xia T et al. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumor Biol 2012; 33: 2349-2355.
125. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y et al. microRNA expression profile in undifferentiated gastric cancer. Int J Oncol 2009; 34: 537-542.
126. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009; 15: 2281-2290.
127. Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F et al. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res 2011; 17: 2725-2733.
128. Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y et al. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. Eur J Gastroenterol Hepatol 2013; 25: 953-957.
129. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261.
130. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37: 1672-1681.
131. Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut 2010; 59: 579-585.
132. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol 2013; 107: 505-510.